Macquarie Group invests in Digital Reasoning to expand AI into finance
Category: #business  By Mateen Dalal  Date: 2019-02-14
  • share
  • Twitter
  • Facebook
  • LinkedIn

Macquarie Group invests in Digital Reasoning to expand AI into finance

Leading developer of Artificial Intelligence (AI) for Human Behavioral Insights (HBI) and Language Process Automation (LPA), Digital Reasoning has recently confirmed a strategic investment made in the company by financial services provider Macquarie Group.

Apparently, the AI tech company would also be partnering with Macquarie for exploring new and innovative uses for its award-winning technology in financial services. It would also look to take advantage of the global presence of Macquarie and accelerate the expansion of its business into Asia and Australia.

According to Digital Reasoning, the investment from Macquarie represents an extensions of the $30 million Series D-1 funding round it had concluded in March 2018. BNP Paribas had reportedly led the round with the other participants being Goldman Sachs, HCA, Barclays, Nasdaq, Square Capital, Lemhi Ventures as well as Partnership Fund for New York City.

Digital Reasoning said the development of the company’s technology and its successful implementation can be attributed to the depth and range of partnerships it has forged with world-leading financial services and healthcare companies.

Miki Edelman, Macquarie Group’s Head of Strategic Client Solutions, Cash Equities, commented that Digital Reasoning has a proven success in delivering solutions powered by AI technology and stands apart from other AI tech businesses. Partnering with the company, Macquarie will look to develop use cases and speed up AI innovations for capital markets further, Edelman mentioned.

Digital Reasoning’s Chief Financial Officer, Prakash Ramachandran said key financial institutions are depending on the company increasingly for understanding human behaviors through integrating analysis of audio, text and structured data. He indicated that insights provided by the company help to improve revenues, mitigate risk and enhance efficiencies.

Ramachandran added that Macquarie’s investment highlights the company’s proficiencies and its ability to work within regulatory frameworks. The company will develop new financial services applications and support its expansion into the Asia and Australia market with this partnership, he confirmed.

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal    

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More

More News By Mateen Dalal

Merck to acquire cancer drug maker Peloton Therapeutics for $1.05Bn
Merck to acquire cancer drug maker Peloton Therapeutics for $1.05Bn
By Mateen Dalal

The acquisition would help Merck strengthen its presence in the renal cell carcinoma space and support its cancer drug portfolio. U.S. pharmaceutical conglomerate, Merck & Co. Inc. has recently agreed to purchase Dallas based Peloton Therapeutic...

Ikea invests in India’s one-stop interior design platform Livspace
Ikea invests in India’s one-stop interior design platform Livspace
By Mateen Dalal

The interior design platform had raised over $70 million last year with investment from TPG Growth & Goldman Sachs. The investment is Ikea’s first such deal in India, however it isn’t the company’s dalliance in India’s ...

BioXcel unveils data from Phase 1 study of receptor agonist BXCL501
BioXcel unveils data from Phase 1 study of receptor agonist BXCL501
By Mateen Dalal

Sublingual administration of BXCL501 had achieved drug exposures that will be therapeutic for the acute treatment of agitation Reports confirm that BioXcel Therapeutics (BTI) has recently presented data from its Phase 1 pharmacokinetic (bioavailabil...